Rights and permissions
About this article
Cite this article
NICE offers a second look at denosumab . . .. Pharmacoecon. Outcomes News 656, 15 (2012). https://doi.org/10.2165/00151234-201206560-00029
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206560-00029